Orchestra BioMed Holdings (OBIO) Financial Statements

101 Followers

Orchestra BioMed Holdings Financial Overview

Orchestra BioMed Holdings's market cap is currently $232.33M. The company's EPS TTM is $-1.28; its P/E ratio is -3,008.78; Orchestra BioMed Holdings is scheduled to report earnings on March 12, 2026, and the estimated EPS forecast is $-0.43. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 25	Mar 25	Dec 23	Dec 22	Dec 21
Income Statement
Total Revenue	$ 33.48M	$ 2.64M	$ 2.76M	$ 3.53M	$ -782.00K
Gross Profit	$ 33.29M	$ 2.43M	$ 2.57M	$ 3.21M	$ -981.00K
Operating Income	$ -51.81M	$ -64.30M	$ -51.51M	$ -32.66M	$ -21.80M
EBITDA	$ -51.48M	$ -63.99M	$ -51.22M	$ -32.44M	$ -21.62M
Net Income	$ -52.95M	$ -61.02M	$ -49.12M	$ -33.61M	$ -23.01M
Balance Sheet
Cash & Short-Term Investments	$ 106.51M	$ 66.81M	$ 87.59M	$ 83.78M	$ 10.90M
Total Assets	$ 114.86M	$ 76.17M	$ 95.21M	$ 95.57M	$ 13.53M
Total Debt	$ 1.69M	$ 16.53M	$ 1.69M	$ 11.87M	$ 5.67M
Net Debt	$ -33.00M	$ -5.73M	$ -28.87M	$ -7.91M	$ -4.26M
Total Liabilities	$ 51.48M	$ 43.22M	$ 27.17M	$ 43.04M	$ 84.76M
Stockholders' Equity	$ 63.38M	$ 32.96M	$ 68.04M	$ 52.53M	$ -71.23M
Cash Flow
Free Cash Flow	$ -49.45M	$ -50.85M	$ -46.20M	$ -29.88M	$ -19.70M
Operating Cash Flow	$ -48.96M	$ -50.56M	$ -46.13M	$ -29.29M	$ -19.43M
Investing Cash Flow	$ -26.94M	$ 13.09M	$ 10.69M	$ -64.12M	$ 13.02M
Financing Cash Flow	$ 88.33M	$ 29.17M	$ 46.22M	$ 103.26M	$ -3.99M

Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History

Income Statement >

Orchestra BioMed Holdings Debt to Assets

Balance Sheet >

Orchestra BioMed Holdings Cash Flow

Cash Flow >

Orchestra BioMed Holdings Forecast EPS vs Actual EPS

Earnings >